Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stolley, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stolley, P. D.
(Chest. 1973;63:18S-20S.)
© 1973 American College of Chest Physicians

Asthma Mortality: A Possible Explanation of International Variations

Paul D. Stolley M.D., M.P.H.1

1 Associate Professor, Department of Epidemiology, The Johns Hopkins School of Hygiene and Public Health, Baltimore

A review of mortality statistics and medication usage indicates that marketing and consumption of a particular highly concentrated isoproterenol pressurized aerosol nebulizer appears to have contributed to the increased asthma mortality reported in certain countries. Those countries which had high sales volumes for the nebulizers but were spared the increased mortality apparently were protected by virtue of not having licensed this highly concentrated nebulizer.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American College of Chest Physicians.